ID

40991

Description

The Natural History of Solid Organ Cancer Stem Cells (SOCSC); ODM derived from: https://clinicaltrials.gov/show/NCT00923052

Lien

https://clinicaltrials.gov/show/NCT00923052

Mots-clés

Versions (1)
  1. 08/06/2020 08/06/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

8 juin 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Hepatic Cancer NCT00923052

    Anglais

    Eligibility Hepatic Cancer NCT00923052

    1 Formulaires  
    Criteria
    Description

    Criteria

    surgery must meet criteria b-e.)
    Description

    Operative Surgical Procedures Criteria Fulfill

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0543467
    UMLS CUI [1,2]
    C0243161
    UMLS CUI [1,3]
    C1550543
    patients with radiographic evidence of, biochemical evidence of, and/or histologically/cytologically proven solid organ cancer, including hepatobiliary cancer, pancreatic cancer, colorectal cancer, gastric cancer, breast cancer, adrenal cancer, mesothelioma, anal cancer, female reproductive tract cancer (ovarian, uterine and cervical), melanoma, and sarcoma.
    Description

    Solid organ Neoplasm | Hepatobiliary neoplasm | Pancreatic carcinoma | Colorectal Carcinoma | Stomach Carcinoma | Breast Carcinoma | Adrenal Cancer | Mesothelioma | Anal carcinoma | Ovarian neoplasm | Uterine Cancer | Cervix carcinoma | Melanoma | Sarcoma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0440790
    UMLS CUI [1,2]
    C0027651
    UMLS CUI [2]
    C0854196
    UMLS CUI [3]
    C0235974
    UMLS CUI [4]
    C0009402
    UMLS CUI [5]
    C0699791
    UMLS CUI [6]
    C0678222
    UMLS CUI [7]
    C0750887
    UMLS CUI [8]
    C0025500
    UMLS CUI [9]
    C0279637
    UMLS CUI [10]
    C0919267
    UMLS CUI [11]
    C0153567
    UMLS CUI [12]
    C0302592
    UMLS CUI [13]
    C0025202
    UMLS CUI [14]
    C1261473
    patients with rare solid organ cancers including but not limited to small intestine, vagina, vulva, carcinoid, skin, pediatric cancers, kaposi s sarcoma, and cancers of unknown origin.
    Description

    Solid organ Neoplasms Rare | Small intestine carcinoma | Vagina Carcinoma | Malignant neoplasm of vulva | Carcinoid Tumor | Skin carcinoma | Malignant Childhood Neoplasm | Kaposi Sarcoma | Carcinoma of unknown primary

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0440790
    UMLS CUI [1,2]
    C0027651
    UMLS CUI [1,3]
    C0522498
    UMLS CUI [2]
    C0238196
    UMLS CUI [3]
    C0262659
    UMLS CUI [4]
    C0375071
    UMLS CUI [5]
    C0007095
    UMLS CUI [6]
    C0699893
    UMLS CUI [7]
    C0278704
    UMLS CUI [8]
    C0036220
    UMLS CUI [9]
    C0220647
    patients with premalignant neoplasms who are scheduled to undergo surgery or biopsy as part of their diagnostic evaluation.
    Description

    Premalignant Neoplasm | Operative Surgical Procedures Scheduled | Biopsy Scheduled

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1335472
    UMLS CUI [2,1]
    C0543467
    UMLS CUI [2,2]
    C0205539
    UMLS CUI [3,1]
    C0005558
    UMLS CUI [3,2]
    C0205539
    patients with a family history of familial or hereditary solid organ cancers or a clinical suspicion for a familial cancer (these patients may show no evidence of disease at the time of enrollment).
    Description

    Family history Solid organ Neoplasms | Suspicion Hereditary Malignant Neoplasm

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0241889
    UMLS CUI [1,2]
    C0440790
    UMLS CUI [1,3]
    C0027651
    UMLS CUI [2,1]
    C0242114
    UMLS CUI [2,2]
    C1333600
    patients must have an ecog performance score of 0-2.
    Description

    ECOG performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    patients must be 16 years of age or older.
    Description

    Age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    patients must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to biopsy or surgery. note: not applicable for healthy relatives having blood analyzed for dna only.
    Description

    Normal Laboratory Test Result | Physical Examination Parameters Normal

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0438214
    UMLS CUI [2,1]
    C0031809
    UMLS CUI [2,2]
    C0449381
    UMLS CUI [2,3]
    C0205307
    patients must be seronegative for hiv antibody, hepatitis b surface antigen and hepatitis c antibody, with the exception of patients with hepatocellular cancers, who must be seronegative for hiv antibody only. note: not applicable for healthy relatives having blood analyzed for dna only.
    Description

    HIV Antibody Seronegative | Hepatitis B Surface Antigens Seronegative | Hepatitis C Antibody Seronegative | Exception Liver carcinoma

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0019683
    UMLS CUI [1,2]
    C0521144
    UMLS CUI [2,1]
    C0019168
    UMLS CUI [2,2]
    C0521144
    UMLS CUI [3,1]
    C0166049
    UMLS CUI [3,2]
    C0521144
    UMLS CUI [4,1]
    C1705847
    UMLS CUI [4,2]
    C2239176
    patients undergoing treatment for their neoplasm under other current nih protocols may be eligible.
    Description

    Cancer treatment Study Protocol Other

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0920425
    UMLS CUI [1,2]
    C2348563
    UMLS CUI [1,3]
    C0205394
    note: patients will not undergo surgery or biopsy for the sole purpose of tissue procurement.
    Description

    Tissue Procurement Excluded

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0040300
    UMLS CUI [1,2]
    C1709695
    UMLS CUI [1,3]
    C0332196
    Retour au début de la page

    Similar models

    Eligibility Hepatic Cancer NCT00923052

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Operative Surgical Procedures Criteria Fulfill
    Item
    surgery must meet criteria b-e.)
    boolean
    C0543467 (UMLS CUI [1,1])
    C0243161 (UMLS CUI [1,2])
    C1550543 (UMLS CUI [1,3])
    Solid organ Neoplasm | Hepatobiliary neoplasm | Pancreatic carcinoma | Colorectal Carcinoma | Stomach Carcinoma | Breast Carcinoma | Adrenal Cancer | Mesothelioma | Anal carcinoma | Ovarian neoplasm | Uterine Cancer | Cervix carcinoma | Melanoma | Sarcoma
    Item
    patients with radiographic evidence of, biochemical evidence of, and/or histologically/cytologically proven solid organ cancer, including hepatobiliary cancer, pancreatic cancer, colorectal cancer, gastric cancer, breast cancer, adrenal cancer, mesothelioma, anal cancer, female reproductive tract cancer (ovarian, uterine and cervical), melanoma, and sarcoma.
    boolean
    C0440790 (UMLS CUI [1,1])
    C0027651 (UMLS CUI [1,2])
    C0854196 (UMLS CUI [2])
    C0235974 (UMLS CUI [3])
    C0009402 (UMLS CUI [4])
    C0699791 (UMLS CUI [5])
    C0678222 (UMLS CUI [6])
    C0750887 (UMLS CUI [7])
    C0025500 (UMLS CUI [8])
    C0279637 (UMLS CUI [9])
    C0919267 (UMLS CUI [10])
    C0153567 (UMLS CUI [11])
    C0302592 (UMLS CUI [12])
    C0025202 (UMLS CUI [13])
    C1261473 (UMLS CUI [14])
    Solid organ Neoplasms Rare | Small intestine carcinoma | Vagina Carcinoma | Malignant neoplasm of vulva | Carcinoid Tumor | Skin carcinoma | Malignant Childhood Neoplasm | Kaposi Sarcoma | Carcinoma of unknown primary
    Item
    patients with rare solid organ cancers including but not limited to small intestine, vagina, vulva, carcinoid, skin, pediatric cancers, kaposi s sarcoma, and cancers of unknown origin.
    boolean
    C0440790 (UMLS CUI [1,1])
    C0027651 (UMLS CUI [1,2])
    C0522498 (UMLS CUI [1,3])
    C0238196 (UMLS CUI [2])
    C0262659 (UMLS CUI [3])
    C0375071 (UMLS CUI [4])
    C0007095 (UMLS CUI [5])
    C0699893 (UMLS CUI [6])
    C0278704 (UMLS CUI [7])
    C0036220 (UMLS CUI [8])
    C0220647 (UMLS CUI [9])
    Premalignant Neoplasm | Operative Surgical Procedures Scheduled | Biopsy Scheduled
    Item
    patients with premalignant neoplasms who are scheduled to undergo surgery or biopsy as part of their diagnostic evaluation.
    boolean
    C1335472 (UMLS CUI [1])
    C0543467 (UMLS CUI [2,1])
    C0205539 (UMLS CUI [2,2])
    C0005558 (UMLS CUI [3,1])
    C0205539 (UMLS CUI [3,2])
    Family history Solid organ Neoplasms | Suspicion Hereditary Malignant Neoplasm
    Item
    patients with a family history of familial or hereditary solid organ cancers or a clinical suspicion for a familial cancer (these patients may show no evidence of disease at the time of enrollment).
    boolean
    C0241889 (UMLS CUI [1,1])
    C0440790 (UMLS CUI [1,2])
    C0027651 (UMLS CUI [1,3])
    C0242114 (UMLS CUI [2,1])
    C1333600 (UMLS CUI [2,2])
    ECOG performance status
    Item
    patients must have an ecog performance score of 0-2.
    boolean
    C1520224 (UMLS CUI [1])
    Age
    Item
    patients must be 16 years of age or older.
    boolean
    C0001779 (UMLS CUI [1])
    Normal Laboratory Test Result | Physical Examination Parameters Normal
    Item
    patients must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to biopsy or surgery. note: not applicable for healthy relatives having blood analyzed for dna only.
    boolean
    C0438214 (UMLS CUI [1])
    C0031809 (UMLS CUI [2,1])
    C0449381 (UMLS CUI [2,2])
    C0205307 (UMLS CUI [2,3])
    HIV Antibody Seronegative | Hepatitis B Surface Antigens Seronegative | Hepatitis C Antibody Seronegative | Exception Liver carcinoma
    Item
    patients must be seronegative for hiv antibody, hepatitis b surface antigen and hepatitis c antibody, with the exception of patients with hepatocellular cancers, who must be seronegative for hiv antibody only. note: not applicable for healthy relatives having blood analyzed for dna only.
    boolean
    C0019683 (UMLS CUI [1,1])
    C0521144 (UMLS CUI [1,2])
    C0019168 (UMLS CUI [2,1])
    C0521144 (UMLS CUI [2,2])
    C0166049 (UMLS CUI [3,1])
    C0521144 (UMLS CUI [3,2])
    C1705847 (UMLS CUI [4,1])
    C2239176 (UMLS CUI [4,2])
    Cancer treatment Study Protocol Other
    Item
    patients undergoing treatment for their neoplasm under other current nih protocols may be eligible.
    boolean
    C0920425 (UMLS CUI [1,1])
    C2348563 (UMLS CUI [1,2])
    C0205394 (UMLS CUI [1,3])
    Tissue Procurement Excluded
    Item
    note: patients will not undergo surgery or biopsy for the sole purpose of tissue procurement.
    boolean
    C0040300 (UMLS CUI [1,1])
    C1709695 (UMLS CUI [1,2])
    C0332196 (UMLS CUI [1,3])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial